Cargando…

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity

INTRODUCTION: Laser photocoagulation is the current gold standard treatment for proliferative retinopathy of prematurity (ROP). However, it permanently reduces the visual field and might induce myopia. Vascular endothelial growth factor (VEGF) inhibitors for the treatment of ROP may enable continuin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pertl, Laura, Steinwender, Gernot, Mayer, Christoph, Hausberger, Silke, Pöschl, Eva-Maria, Wackernagel, Werner, Wedrich, Andreas, El-Shabrawi, Yosuf, Haas, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470662/ https://www.ncbi.nlm.nih.gov/pubmed/26083024 http://dx.doi.org/10.1371/journal.pone.0129383

Ejemplares similares

Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion
por: Steinbrugger, Iris, et al.
Publicado: (2009)

Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration
por: Mattes, Dietmar, et al.
Publicado: (2009)

Vitreous hyper-reflective dots in pseudophakic cystoid macular edema assessed with optical coherence tomography
por: Glatz, Wilfried, et al.
Publicado: (2017)

Association between Polymorphism of the Vitamin D Metabolism Gene CYP27B1 and HLA-B27-Associated Uveitis. Is a State of Relative Immunodeficiency Pathogenic in HLA B27-Positive Uveitis?
por: Steinwender, Gernot, et al.
Publicado: (2013)

Associations of VEGF Polymorphisms With Retinopathy of Prematurity
por: Ling, Xiao Chun, et al.
Publicado: (2023)

Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients
por: Maier, Richard, et al.
Publicado: (2008)

TNF-α –308 G>A and –238 G>A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma
por: Mossböck, Georg, et al.
Publicado: (2009)

Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma
por: Mossböck, Georg, et al.
Publicado: (2011)

Effect of intravitreal C(3)F(8) gas in patients with vitreomacular traction: A retrospective case series
por: Haas, Anna-Maria, et al.
Publicado: (2017)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF(165)b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
por: Zhao, Min, et al.
Publicado: (2015)

Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV?
por: Boltz, Agnes, et al.
Publicado: (2010)

Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)
por: Li, Zijing, et al.
Publicado: (2018)

Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
por: Gangwe, Anil, et al.
Publicado: (2021)

Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries
por: Dogra, Mangat Ram, et al.
Publicado: (2023)

Targeting VEGF in canine oxygen-induced retinopathy – a model for human retinopathy of prematurity
por: McLeod, D Scott, et al.
Publicado: (2016)

Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2021)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
por: Velez-Montoya, Raul, et al.
Publicado: (2010)

Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity
por: Goswami, Binita, et al.
Publicado: (2015)

Anti-vascular endothelial growth factor therapy in retinopathy of prematurity: An updated literature review
por: Alzuabi, Asma K., et al.
Publicado: (2022)

Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review
por: Tan, Qing-Qing, et al.
Publicado: (2019)

Use of intravitreal anti-VEGF: Retinopathy of prematurity surgeons’ in Hamlet's dilemma?
por: Azad, Rajvardhan
Publicado: (2011)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
por: Zhao, Yue, et al.
Publicado: (2018)

RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2022)

„Die Familienanamnese bringt Licht ins Dunkel“
por: Woltsche, N., et al.
Publicado: (2021)

Evaluation of Acanthamoeba keratitis cases in a tertiary medical care centre over 21 years
por: List, Wolfgang, et al.
Publicado: (2021)

The impact of surgeon’s experience and sex on the incidence of cystoid macular edema after uneventful cataract surgery
por: List, Wolfgang, et al.
Publicado: (2022)

Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes
por: Kang, Hyun Goo, et al.
Publicado: (2018)

The Relationship between the Aqueous VEGF Level and the Severity of Type 1 Retinopathy of Prematurity
por: Liang, Tianwei, et al.
Publicado: (2022)

Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity
por: Geisen, P., et al.
Publicado: (2008)

Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti-VEGF: A Comparison Study
por: Ghassemi, Fariba, et al.
Publicado: (2022)

Effects of Type 2 Diabetes Mellitus and Smoking on Changes in Corneal Endothelial Morphology and Cell Density
por: Antičić-Eichwalder, Marija, et al.
Publicado: (2022)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Cholesterol and glaucoma: a systematic review and meta‐analysis
por: Posch‐Pertl, Laura, et al.
Publicado: (2021)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
por: Chen, Xuting, et al.
Publicado: (2019)

Commentary: Looking beyond anti-vascular endothelial growth factor – Novel therapeutic targets for retinopathy of prematurity
por: Dogra, Mohit, et al.
Publicado: (2021)

Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity
por: Sindal, Manavi D, et al.
Publicado: (2021)

High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Correction: High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Laser versus Anti-VEGF: A Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity
por: Hartnett, M. Elizabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4b8j0ceindbn8ehgh1rbuj4j88